Compound ID | 507
Class: Fluoroquinolone
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Upon infection of quinolone resistant- S. aureus into mice the effective dose was 7.8mg/kg in comparison to tosufloxacin with >100mg/ml |
| Description: | Hayashi N, Amano H, Ohshita Y, et al. In vitro and in vivo acctivities, pharmacokinetics and toxicity of WQ-2756 and WQ-2765. |
| Institute where first reported: | Wakunaga Pharmaceuticals, Japan |
| Year first mentioned: | 1996 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Reason Dropped: | Poor pharmokinetics |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/9803202 |
| Citation: |